The in vivo evaluations using the 4T1 xenograft BALB/c mouse model showed that CA4-encapsulated nanoliposomes started proliferating at the tumor site 3 h after injection, with the most significant tumor accumulation at 24 h. This evidence concerns the gene CA4 and neoplasm.